Journal of Community Genetics | 2019
Contentious ethical issues in community genetics: let’s talk about them
Abstract
“Community genetics is the art and science of the responsible and realistic application of health and disease-related genetics and genomics knowledge and technologies in human populations and communities to the benefit of individuals therein. Community genetics is multi-, interand transdisciplinary and aims to maximize benefits while minimizing the risk of harm, respecting the autonomy of individuals and ensuring equity.” (Ten Kate et al. 2010). In the light of this definition, any disrespect for the autonomy of individuals is morally questionable. However, autonomy of the individual cannot be absolute. Individual rights and duties always need to be balanced with those of the community, and there is considerable cultural variability as to where to draw the lines. As Editors of this Journal, although personally rooted in the cultural tradition of the “Western individualism”, we feel obliged to accept this variability and understand the Journal also as a forum for discussing ethical diversity. We neither wish to exert any kind of “ethical imperialism” nor do we want to promote unreflected “ethical relativism”. Doing so, we must accept walking on “thin ice” at times. “Economic gains or eugenic aims are not the goal of community genetics.” (Ten Kate et al. 2010). Two recent papers in this Journal have touched these central issues (Sinha et al. 2019; Singer et al. 2019). It was our decision to accept these papers and have them accompanied by invited editorials (Modell 2019; Bittles 2019). The article “Haemoglobinopathies in India: estimates of blood requirements and treatment costs for the decade 2017– 2026” by Sinha et al. stated: “To avert a public health crisis there is an urgent need to fully implement the prevention programme for haemoglobinopathies”, which would include carrier screening programmes. Is such an argument in conflict with the statements in the paper of ten Kate et al.? We believe that there is no clear yes or no as an answer to this question. When the goal of a carrier screening programme is to enable couples to make an informed reproductive choice, the consequence will often be a reduced prevalence, but this interpretation of goal and consequence is not shared by all. Also in genetic counselling decades ago there was discussion about the goal of genetic services: prevention vs. helping clients to make their own informed decisions (Biesecker 2001). They noted discrepancies in whether the goals to prevent had a societal intent or were individualized. In fact, prevention programmes aiming at reducing the birth prevalence of genetic diseases have often been underpinned by economic arguments. Resource allocation in medicine always bears ethical dilemmas including direct or indirect exertion on individuals, and publicly funded carrier screening programmes are no exception (Schmidtke 1998; DeWert et al. 2012; Rogowski et al. 2014). Different societies will differ in the presence of directive elements contained in such programmes, and in the possibilities of people to react to them. The article “Consanguinity and Genetic Diseases Among the Bedouin Population in the Negev” by Singer et al. contains several contentious issues, some of which were addressed in the Editorial by Alan Bittles (2019). One particular aspect here is reproductive choice in a society with a tradition of strict obedience to marriage rules in favour of consanguineous mating leading to high rates of infant mortality and accumulation of recessive diseases in this population. The authors suggest implementing genetic counselling and “medical approval” prior to marriage as measures of intervention in specific tribes. * Jörg Schmidtke [email protected]